Being an Early Career Investigator at AHA21

Over 50 emerging scientists and clinicians were among the finalists of the Early Career Investigator Award in AHA Scientific Sessions 2021. These prestigious awards were designed to recognize the marvelous endeavors by early career investigators who submitted their abstracts to AHA Scientific Sessions 2021. The selection process included not only the quality of the abstracts … Read more

Climate Change is a Biomedical and Healthcare Crisis

One thing that has been on my mind, and surely it must have crossed yours recently, is the fact that our planet’s climate, and the environment, are having an increasing impact on how healthcare and society functions. The frequency of extreme weather events is plain to see and often experience (heatwaves, fires, storms, floods, droughts, … Read more

Let’s add Stress Reduction as the 8th step in the American Heart Association’s “Life’s Simple 7”

February is Heart Month!  An entire month dedicated to heart disease awareness in our community.  During this month, we also educate the community on why heart disease is a women’s biggest threat.  After all, heart disease takes more lives than all cancers combined.  Globally, that equates to one woman dying every 80 seconds.  More recently, … Read more

Start 2021 in a Good Night Sleep

Should you make new year’s resolutions? Many may think the new year’s resolutions are meaningless. Especially after a year of frustration and uncertainty, New year’s resolutions seem less encouraging. A few small and attainable goals could help to provide a sense of purpose and improve our well-being. The most popular goals for new year’s resolutions … Read more

Building Your Brand: Research Career Planning and Scientific Writing

AHA 20 had a fantastic session titled “Building Your Brand” and it provided excellent insights on how to be a successful researcher in academic medicine. Panel participants Dr. Erin Michos, Dr. Louise McCullough, Dr. Andrew Landstrom, and Dr. Pradeep Natarajan shared their stories on how they got involved in research and the lessons they learned … Read more

DAPA-CKD: Is SGLT2i the ANSWER? Will the guidelines change?

Over the past years, series of clinical trials prove the beneficial effect of glucose cotransporter 2 (SGLT2) inhibitors in reducing the risk of cardiovascular events in people with type 2 diabetes mellitus. The results from these trials were consistent, significant, and demonstrated a considerable reduction in heart failure hospitalization among patients who used SGLT2 inhibitors, … Read more